Rosy  Wills

Rosy Wills

Followers 0
Following 0
According to the new market research report Tangential Flow Filtration Market is expected to grow from USD 944 million in 2019 to USD 1,590 million by 2024 at a CAGR of 11.0% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=72081607Market growth is largely driven by factors such as increasing adoption of single-use technologies, advantages of tangential flow filtration over normal flow filtration and increased cGMP adoption.Based on material type, the global tangential flow filtration market is divided into PES/PS, regenerated cellulose, and other materials.The PES/PS segment is expected to account for the largest share of the global TFF market in 2019.The hydrophilic nature of PES/PS, its low protein-binding properties, and wide range of applications, such as ultrafiltration of downstream processing, product concentration, and the filtration of biological and pharmaceutical solutions, is expected to drive the demand for this material.Tangential flow filtration systems segment to account for the largest share of the global TFF Market in 2019Based on the product, the TFF System Market is segmented into systems, membrane filters, and accessories.The systems segment is expected to account for the largest share of the market in 2019, owing to factors such as the increasing use of different single-use systems among end users due to their advantages, such as a reduced need for product validation and cleaning.Bioprocess applications projected to account for the largest application segment of the market in 2019Based on application, the market is segmented into bioprocess applications, viral vector and vaccine purification, and other applications such as drug formulation, blood plasma fractionation, media and buffer preparation, and pharmaceutical water purification.The bioprocess applications segment is expected to dominate the market in 2019 owing to factors such as growth in the overall biopharmaceutical industry, increasing biologics research, and significant growth in biologics research funding.The major companies in the global TFF Market are Merck Millipore (US), Danaher Corporation (US), Sartorius AG (Germany), GE Healthcare (US), and Repligen Corporation (US).Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=72081607North America is projected to account for the largest share of the Tangential Flow Filtration Market in 2019In 2019, North America is expected to account for the largest share of the TFF System Market, followed by Europe.The largest share of the North American market is attributed to the presence of a well-established biopharmaceutical industry and significant R spending by pharmaceutical and biotechnology companies.
According to research report the clinical alarm management market is expected to reach $1,724 million by 2023 from an estimated $457 million in 2018, at a CAGR of 30.4% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=69939577Based on component, the global clinical alarm management market is segmented into two broad categories based on component, namely— solutions and services.The services segment is expected to grow at the highest CAGR during the forecast period owing to the increasing adoption of clinical alarm management solutions and indispensable and recurring nature of services.Based on product, the global clinical alarm management market is categorized into nurse call systems, physiological monitors, EMR integration systems, bed alarms, ventilators, and others (infusion pumps and pulse oximeters).The EMR integration systems segment is also expected to grow at the highest rate during the forecast period owing to the increased adoption of EHRs and other interoperability solutions in healthcare organizations, growing regulatory requirements & healthcare reforms, shift of point-of-care diagnostics from hospitals to home care settings, and the need for integrated healthcare systems to improve the quality and outcome of healthcare systems.The major players in the clinical alarm management market include Koninklijke Philips (Netherlands), Vocera Communications (US), Mobile Heartbeat (US), GE Healthcare (US), Ascom Holdings (Switzerland), Spok, Inc. (US), Bernoulli Enterprise (US), Connexall (Canada), Capsule Technologie (US), and Masimo Corporation (US).These players have adopted various growth strategies, such as product launches and enhancements; acquisitions; expansions; and agreements, partnerships, mergers, and collaborations.Product launches and partnerships and have been the most dominating strategy adopted by major players of clinical alarm software market from 2015 to 2018, which helped them to innovate on their offerings and broaden their customer base.Recent Developments -• In October 2017, GE Healthcare (US) entered into partnership with Ascom (Switzerland) to enable the addition of alarm management solution called Digistat Patient Watch to GE Healthcare’s portfolio of solutions for the intensive care.• In August 2017, Ascom (Switzerland) partnered with Dräger (Germany) to deliver clinical alarm management solutions to healthcare providers.• In October 2016, Vocera Communications (US) acquired Extension Healthcare (US).This was expected to enable Vocera add Extension Healthcare’s complementary software to Vocera’s Communication Platform and expand customer relationships and grow software revenue faster by providing highly relevant cross-selling opportunities.Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=69939577North America is estimated to account for the largest share of the clinical alarm software market in 2018.
According to the new market research report Ambulatory EHR Market is expected to reach USD 6.8 billion by 2025 from USD 5.2 billion in 2020, at a CAGR of 5.7% during the forecast period of 2020 to 2025.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235617627The key factors propelling the growth of the global ambulatory EHR market are government support for the adoption of HCIT, an increase in the COVID-19 patient volume, growing usage of EHR solutions, and the need to curtail healthcare costs.On the other hand, heavy infrastructure investments and the high cost of deployment are limiting the growth of the global market to a certain extentThe cloud-based solutions segment is projected to occupy the majority of the market share during the forecast period.Based on delivery mode, the hospital EHR market is segmented into on-premise and cloud-based solutions.In 2019, the cloud-based solutions segment accounted for the largest share of the market.The market is mainly driven by the advantages associated with cloud-based solutions, which include flexibility and cost reductions in healthcare delivery.Practice management application is the largest application segment in the marketOn the basis of application, the global market has been segmented into practice management, patient management, e-prescribing, referral management, population health management, decision support, and health analytics.The practice management segment commanded the largest share of the global ambulatory EHR market in 2019.The significant share of this application segment can primarily be attributed to the wide range of advantages associated with practice management solutions, including increased efficiency of day-to-day operations, enhanced value of services provided to patients, and improved adherence to compliance requirements.In 2019, North America accounted for the largest share of the market.The ambulatory EHR market is predominantly divided into five major geographies, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
According to research report the Contrast Media Contrast Agent Market is expected to reach USD 6.0 billion by 2024 from an estimated USD 5.0 billion in 2019, growing at a CAGR of 3.8% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911Growth in the market can primarily be attributed to the rising volume of CT and MRI examinations globally, and the rapidly growing cancer and CVD population across the globe, increasing number of approvals of contrast agents.Rising research activities on contrast agents & their applications are the key areas of opportunity in this marketGE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), and Guerbet (France) are some of the leading players in the Contrast Media Contrast Agent Market.Other prominent players in the market are Lantheus (US), Daiichi Sankyo (Japan), Unijules (India), J.B.Chemicals (India), Sanochemia (Austria), Taejoon Pharm (South Korea), Jodas (India), and Magnus Health (India).Recent Developments:> In 2017, GE Healthcare (US) launched a new Macrocyclic MRI contrast agent, Clariscan, in Europe.> In 2019, Bayer AG (Germany) received FDA approval for Gadavist as the first contrast agent for cardiac MRI.> In 2019, Guerbet Group partnered with IBM Watson Health for AI in medical imaging to support liver cancer diagnostics, utilizing CT and MRI imaging.Based on type, the contrast media market is segmented into iodinated contrast media, gadolinium-based contrast media, barium-based contrast media, and microbubble contrast media.In 2019, the iodinated contrast media segment is estimated to account for the largest share of the contrast media industry.The large share of this segment can be attributed due to its high usage in CT examinations coupled with the fact that it can be used in almost all body parts.Based on modality, the contrast agent market is segmented into X-ray/CT, MRI, and ultrasound procedures.
According to research report the medical device contract manufacturing market is projected to reach USD 91.3 billion in 2024 from an estimated USD 55.0 billion by 2024, at a CAGR of 10.6% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170622851Factors such as increasing automation in the manufacturing of medical devices and advanced technologies integrating electronics and medical devices are expected to drive the growth of the medical device outsourcing market.The increased connectivity and data-gathering capabilities of these technologies make it possible to build high-volume, regulation-compliant manufacturing processes with efficient inventory and production management.With the increasing adoption of Industry 4.0 technologies in manufacturing critical and sophisticated medical devices, the medical device contract manufacturing market is expected to grow significantly during the forecast period.Class II medical devices are estimated to hold the largest share of the medical device outsourcing market in 2019Class II medical devices are expected to account for a major share of the market in 2019, followed by Class I and Class III devices, respectively.The large share of this segment can be attributed to the large number of medical devices that fall under this device class and fewer regulatory compliance necessities than Class III devices.The IVD devices segment is expected to account for the largest share of the medical device contract manufacturing market in 2019In 2019, the IVD devices segment is likely to account for the largest share of the medical device outsourcing market.The share of this segment can be attributed to the increasing volume of IVD tests performed globally, a growing number of hospitals and clinical laboratories in developing countries, automation and technological advancements in instruments with high-throughput capabilities, and advances in life science research.By service type, the device development and manufacturing services segment is estimated to account for the largest share of this market in 2019In 2019, the device development and manufacturing services segment is expected to account for the largest share of the global medical device outsourcing market.The increasing adoption of contract manufacturing services by OEMs in the medical device industry, growing consumption of medical devices, and the improving capabilities for device development and manufacturing are the major factors responsible for the large share of the device development and manufacturing services segment.APAC is expected to dominate the market in 2019APAC is estimated to account for the largest share of the medical device outsourcing market in 2019, followed by North America.
According to the new market research report Life Science Analytics Market is expected to reach 42.0 billion by 2025 from USD 22.1 billion in 2020, at a CAGR of 13.7% during the forecast period of 2020 to 2025.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174990653Growth in this life science analytics software market is mainly driven by technological advancements, big data in the life science industry, growing adoption of analytics solutions in clinical trials, increasing adoption of analytics for sales & marketing applications, need for improved data standardization, increasing prevalence of chronic diseases, growing pressure to curb healthcare spending, and the need for improved patient outcomes.On the other hand, high implementation costs are expected to restrain the growth of this market to a certain extent.Based on application, the life science analytics market is segmented into research & development (clinical trials and preclinical trials), sales & marketing, regulatory compliance, supply chain optimization, and pharmacovigilance.The sales & marketing segment is expected to grow at the highest CAGR during the forecast period.Based on type, the pharmaceutical life science analytics market is segmented into descriptive analytics, predictive analytics, and prescriptive analytics.The descriptive analytics segment accounted for the largest share of the Life Science Analytics Market in 2019.The large share of this segment is attributed to the significant usage of descriptive analytics by stakeholders to gain a better understanding of the past trends and events occurring in real-time.Based on the delivery mode, the Pharmaceutical Life Science Analytics Market is segmented into the on-demand model and the on-premise model.The on-demand model segment is expected to grow at the highest CAGR during the forecast period, owing to advantages such as increasing demand for self-driven analytics, lack of upfront capital investments for hardware, extreme capacity flexibility, and pay-as-you-go pricing of this model.In 2019, North America accounted for the largest market share, followed by Europe.
According to market research report Weight Loss Management Market to grow from USD 175.94 billion in 2017 to USD 245.51 billion by 2022, at a Compound Annual Growth Rate (CAGR) of 6.9% during the forecast period.Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=1152The growth of this market is majorly attributed to the growing rate of obesity, increasing prevalence of lifestyle diseases, and increasing number of bariatric surgeries.Beverages segment to dominate the market in 2017Based on diet, the weight loss and weight management market is segmented into meals, beverages, and supplements.In 2017, the beverages segment is expected to account for the largest share of the weight loss and weight management market.Growth in this segment is majorly driven by the growing diabetic population across the globe.The fitness equipment segment is projected to grow at the highest CAGR during the forecast period.By equipment, the weight loss management market is segmented into fitness equipment and surgical equipment.The fitness equipment segment is estimated to register the highest growth rate during the forecast period.The high growth in this segment can primarily be attributed to the continuous technological advancements in fitness equipment and growing accessibility to gyms.North America to dominate the weight loss and weight management marketIn 2017, North America is expected to dominate the global weight loss management market primarily due to factors such as the increasing incidence of obesity and chronic diseases, rising awareness about nutrition and healthy lifestyles, and growing number of fitness centers in the region.In 2017, Europe is expected to account for the second-largest share of this market.
According to the new market research report Hyperspectral Imaging Market is projected to reach USD 30.0 billion by 2025 from USD 12.4 billion in 2020, at a CAGR of 19.3%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=246979343The Snapshot technology segment is expected to grow at the highest CAGR during the forecast periodBased on technology, the Hyperspectral Imaging Systems Market is segmented into pushbroom (line-scanning), snapshot (single shot), and other technologies [whiskbroom (point-scanning), tunable filters (wavelength scan), and imaging FTIR (time scanning)].The pushbroom segment is estimated to account for the largest share of the market in 2019, while the snapshot segment is projected to register the highest CAGR during the forecast period.This can be attributed to the advantages offered by snapshot hyperspectral imaging systems, which make this technology most suitable for real-time analysis.PERSONALIZE THIS RESEARCH> Triangulate with your Own Data> Get Data as per your Format and Definition> Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor> Any level of PersonalizationIn 2019, the cameras segment accounted for the largest share of the marketOn the basis of product, the Hyperspectral Imaging Market is segmented into cameras and accessories.Cameras are expected to command the larger share of the market, by product, in 2019.Technological advancements, the development of affordable hyperspectral imaging cameras, and the increasing adoption of hyperspectral technology for defense and industrial applications are driving the growth of the hyperspectral cameras segment.The prominent players operating in the Hyperspectral Imaging Market include Headwall Photonics, Inc. (US), Applied Spectral Imaging, Inc. (US), Corning Incorporated (US), Surface Optics Corporation (US), Norsk Elektro Optikk AS (Norway), Resonon, Inc. (US), Specim, Spectral Imaging Ltd. (Finland), Telops, Inc. (Canada), BaySpec, Inc. (US), Cubert GmbH (Germany), inno-spec GmbH (Germany), XIMEA GmbH (Germany), imec (Belgium), and ChemImage Corporation (US).Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=246979343North America was the largest regional market for market in 2019The global Hyperspectral Imaging Market has been divided into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW).North America is expected to account for the largest share of the global market in 2019.
According to the new market research report the Oral Care Market is projected to reach USD 53.3 billion by 2025 from USD 45.8 billion in 2020, at a CAGR of 3.1%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80546246The Factors such as the rising awareness about oral hygiene, growing incidence of dental diseases, and technological advancements in oral care products are expected to drive the growth of the Oral Care Market.Increasing the online purchase of oral care products is expected to create new growth opportunities for players operating in this market.Based on product, the market is categorized into toothpaste, toothbrushes & accessories, mouthwashes/rinses, denture products, dental accessories/ancillaries, and dental prosthesis cleaning solutions.In 2019, the toothpaste segment was expected to account for the largest share of the Oral hygiene Market.The large share of this segment can primarily be attributed to the enormous adoption of toothpaste for maintaining oral hygiene, the treatment of dental caries, and its use in post-surgical procedures.By distribution channel, the Oral Hygiene Market is segmented into consumer stores, retail pharmacies, dental dispensaries, and online distribution.Online distribution is expected to grow at the fastest CAGR in the forecast period in this segment.This high growth can be attributed to the increase in the number of e-commerce platforms focused on oral care/oral hygiene products, better convenience and availability of a variety of products through this channel along with proper discounts.In 2019, the Asia Pacific was estimated to account for the largest share of the Oral hygiene Market, followed by Europe.
1
According to the new market research report Healthcare Integration Market is projected to reach USD 6.0 billion by 2025 from USD 3.5 billion in 2020, at a CAGR of 11.4% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=228536178The increasing need for integration primarily drives the market for healthcare IT integration solutions as a result of the rising healthcare costs and the growing volume of data generated in healthcare systems.The need to improve patient safety and favorable government and private support for HCIT will also contribute to market growth in the coming years.However, the high cost of HCIT integration is limiting the overall adoption of these solutions.The prominent players in this Healthcare Integration Market are Infor (US), InterSystems Corporation (US), Cerner Corporation (US), Orion Health (New Zealand), NextGen Healthcare Inc. (US), iNTERFACEWARE, Inc. (Canada), Allscripts Healthcare Solutions, Inc. (US), Epic Systems Corporation (US), GE Healthcare (US), IBM (US), Oracle Corporation (US), Capsule Technologies, Inc. (US), Koninklijke Philips (Netherlands), AVI-SPL, Inc. (US), Corepoint Health (US), and MEDITECH (US).The services segment is expected to for the largest share of the Healthcare IT Integration Market in 2019.Based on product & service, the market is categorized mainly into products and services.In 2019, the services segment was expected to account for the largest share of the Healthcare IT Integration Solutions Market.The large share of this segment can primarily be attributed to its indispensable nature.In addition to this, the rising need for simplifying workflows in healthcare organizations; the increasing demand for data standardization; and the growing need to build, design, and implement standardized, interoperable networking platforms are also driving the demand for healthcare IT integration services.By end user, the hospital segment is expected to grow at the highest CAGR during the forecast period.Based on end-user, the Healthcare IT Integration Solutions Market is segmented into hospitals, laboratories, clinics, diagnostic imaging centers, and other end users.
According to the new market research report the remote patient monitoring market is projected to reach USD 117.1 billion by 2025 from USD 23.2 billion in 2020, at a CAGR of 38.2% between 2020 and 2025.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=77155492The rising geriatric population and the growing need to expand healthcare access, cost benefits of telehealth and remote patient monitoring, advancements in telecommunications, benefits of RPM to reduce the burden on medical resources, growing incidences of chronic diseases, and increasing investments in telehealth and RPM are the major factors driving the growth of this market.However, the regulatory variations across regions, healthcare fraud, and informal usage of social media practices is expected to restrain the market growth during the forecast period.Some of the prominent players in the remote patient monitoring market are BioTelemetry Inc. (US), Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Cerner Corporation (US), Siemens Healthineers AG Germany, OMRON Healthcare (Japan), Boston Scientific Corporation (US), Abbott Laboratories (US), Resideo Life Care Solutions (US), Vivify Health, Inc. (US), ALTEN Calsoft Labs (France), Preventice Solutions (US), Bio-Beat Technologies (Israel), VitalConnect (US), Welch Allyn (US), Teladoc Health Inc. (US), Dexcom Inc. (US), iRhythm Technologies, Inc. (US), and VivaLNK Inc. (US).Based on end users, the global remote patient monitoring market is broadly segmented into providers, payers, patients, and other end users.The providers segment accounted for the largest share of the global market in 2019.This can be attributed to the increased adoption of remote monitoring in chronically ill and old aged patients, advancements in RPM monitoring devices, and the increasing number of RPM services offered by providers.Based on the product, the market is segmented into software & services and devices.The software and services segment accounted for the largest share of the global market in 2019.The large share of this segment is mainly due to the increasing reimbursement for RPM programs and the rising number of chronic illnesses, thus leading to the growing adoption of RPM services across the globe.Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=77155492In 2019, North America accounted for the largest share of the market, followed by Europe.
According to research report the cancer biomarkers market to reach USD 20.4 billion by 2022. and is estimated to grow at a CAGR of 12.2% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=202The increasing prevalence of cancer, rising government support for research on cancer biomarkers, growing use of biomarkers in drug discovery and development, and increasing use of biomarker tests for diagnostic purposes are the major factors that are driving the growth of this market.The genetic biomarkers segment is expected to grow at the highest CAGR during the forecast periodBased on biomarker type, the market is segmented into genetic biomarkers, protein biomarkers, and other biomarkers (cell, viral, and carbohydrate biomarkers).During the forecast period, the genetic biomarkers segment is estimated to grow at the highest CAGR majorly due to advancements in high-throughput technologies, such as next-generation sequencing, which have enhanced the speed and accuracy of genetic biomarker discovery and diagnosis.The breast cancer segment accounted for the largest share of the cancer biomarkers market in 2016Based on cancer type, the market is segmented into breast, lung, colorectal, prostate, melanoma, leukemia, thyroid, bladder, non-Hodgkins lymphoma, kidney, and other cancers (such as cervical, multiple myeloma, CNS, gastric, liver, pancreatic, oral cavity and pharynx, stomach, and ovarian cancers).The breast cancer segment accounted for the largest share of this market owing to the high and growing prevalence of breast cancer, increasing awareness about breast cancer, rising number of breast cancer screening programs, and growing research on breast cancer.The major players operating in the cancer biomarkers market are Abbott (US), Affymetrix (US), Roche (Switzerland), Illumina (US), QIAGEN (Netherlands), Agilent (US), Thermo Fisher (US), Merck (US), Becton Dickinson and Company (US), and Hologic (US).Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=202North America accounted for the largest share of the cancer biomarkers market in 2017, followed by Europe.Growth in the developed markets of North America and Europe is primarily driven by the high adoption of advanced technologies like NGS, increasing number of research studies for the discovery and development of novel biomarkers, presence of a large number of pharmaceutical companies, rising funding and investments from public and private organizations, and increasing use of biomarkers in patient stratification and drug development process.Contact:Mr. Aashish MehraMarketsandMarkets™ INC.630 Dundee RoadSuite 430Northbrook, IL 60062USA: +1-888-600-6441Email: [email protected]
According to the new market research report "Dental Equipments Market by Product (Dental Imaging Equipment (Panoramic, Sensor, Camera), Lasers, Diode Lasers, Dental Chairs, CAD/CAM, Handpieces, Dental Units, Casting Machines) & End User ( Laboratories, Hospitals, Clinics) - Global Forecast to 2026", published by MarketsandMarkets™, the Dental Equipment Market is estimated to reach USD 6.2 billion in 2021 and is projected to reach USD 8.9 billion by 2026, at a CAGR of 7.7% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=784Due to the increasing prevalence of oral health disorders, sedentary and changing lifestyles, growing consumer awareness, and rising dental tourism.An increasing number of dental laboratories investing in CAD/CAM technologies will provide abundant opportunities.However, the high cost of dental imaging systems and lack of reimbursement for dental procedures are expected to restrain the growth of this market during the forecast period.The therapeutic dental equipment segment accounted for the largest share of dental equipment market in 2020Based on products, the dental equipment market is broadly segmented into therapeutic and diagnostic dental equipment.The therapeutic dental equipment segment is categorized into dental operatory & treatment center equipment, general equipment, and dental lasers.The diagnostic dental equipment segment includes extraoral imaging systems, intraoral imaging systems, and dental imaging software.The dental equipment market has been growing steadily throughout the years due to factors such as the rapidly growing aging population and the increasing incidence of dental disorders and diseases.Dental hospitals & clinics segment accounted for the largest share of dental equipment market in 2020.Based on the end user, the dental equipment market is segmented into hospitals & clinics, academic & research institutes, and other end users.The large market share is attributed to the increasing number of dental clinics and hospitals across the globe, rapid adoption of advanced technologies, increasing dental tourism in emerging markets, and the rising number of group dental practices in developed countries.Asia Pacific is expected to witness the fastest growth during the forecast period of 2021–2026.Geographically, the dental equipment market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
1
According to the new market research report "Dental Equipments Market by Product (Dental Imaging Equipment (Panoramic, Sensor, Camera), Lasers, Diode Lasers, Dental Chairs, CAD/CAM, Handpieces, Dental Units, Casting Machines) & End User ( Laboratories, Hospitals, Clinics) - Global Forecast to 2026", published by MarketsandMarkets™, the Dental Equipment Market is estimated to reach USD 6.2 billion in 2021 and is projected to reach USD 8.9 billion by 2026, at a CAGR of 7.7% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=784Due to the increasing prevalence of oral health disorders, sedentary and changing lifestyles, growing consumer awareness, and rising dental tourism.An increasing number of dental laboratories investing in CAD/CAM technologies will provide abundant opportunities.However, the high cost of dental imaging systems and lack of reimbursement for dental procedures are expected to restrain the growth of this market during the forecast period.The therapeutic dental equipment segment accounted for the largest share of dental equipment market in 2020Based on products, the dental equipment market is broadly segmented into therapeutic and diagnostic dental equipment.The therapeutic dental equipment segment is categorized into dental operatory & treatment center equipment, general equipment, and dental lasers.The diagnostic dental equipment segment includes extraoral imaging systems, intraoral imaging systems, and dental imaging software.The dental equipment market has been growing steadily throughout the years due to factors such as the rapidly growing aging population and the increasing incidence of dental disorders and diseases.Dental hospitals & clinics segment accounted for the largest share of dental equipment market in 2020.Based on the end user, the dental equipment market is segmented into hospitals & clinics, academic & research institutes, and other end users.The large market share is attributed to the increasing number of dental clinics and hospitals across the globe, rapid adoption of advanced technologies, increasing dental tourism in emerging markets, and the rising number of group dental practices in developed countries.Asia Pacific is expected to witness the fastest growth during the forecast period of 2021–2026.Geographically, the dental equipment market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
1
According to the new market research report "Veterinary Dental Equipment Market by Product (dental equipment, Hand instruments, consumables and Adjuvants), Animal type (Small companion and large animal), End User (Hospitals, Clinics, Academic institute) - Global Forecast to 2026", published by MarketsandMarkets™, the market is projected to reach USD 500 million by 2026 from USD 334 million in 2021, at a CAGR of 8.4% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155083837 The Growth in the global companion animal population, rising incidence of veterinary dental problems, and growth in the number of veterinary practitioners and their income levels in developed economies are the primary drivers for the veterinary dental equipment market.However, the increasing cost of pet care is expected to restrain the growth of this market to a certain extent.This problem will be further exacerbated by the low animal health awareness and a shortage of skilled veterinarians in emerging markets.The large share of this segment can be attributed to the high cost of dental equipment and the rising income level of veterinarians, which is resulting in the higher adoption of dental equipment.On the basis of animal type, small companion animal segment expected to grow at the highest CAGR in the market in the forecast period Based on animal type, the veterinary dental equipment market is segmented into small companion animals and large animals.
According to the new market research report Clinical Microbiology Testing Market is estimated to be USD 3.9 billion in 2020 and projected to reach USD 5.3 billion by 2025, at a CAGR of 6.5%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219135367The increasing prevalence of infectious diseases and growing outbreak of epidemics (such as COVID-19), technological advancements, and increased funding and public-private investments are the key factors driving the growth of the orthopedic braces and supports the industry.The clinical microbiology market includes major Tier I and II suppliers like bioMérieux (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), and Roche Diagnostics (Switzerland).Other prominent players include Thermo Fisher Scientific (US), QIAGEN (Netherlands), 3M (US), Bio-Rad Laboratories (US), Bruker Corporation (US), and Hologic (US).These suppliers have their manufacturing facilities spread across regions such as North America and Europe.COVID-19 has impacted their businesses as well.Demand for clinical microbiology from key end-users has declined a bit amidst the global COVID-19 pandemic.Industry experts believe that COVID-19 will have a short-term decline in the growth for the microbial testing market in 2020, but will experience normal development as the market gradually steadies by the end of 2020.Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=219135367Demand for conventional laboratories result in the segment occupying the high share of the clinical microbiology marketThe product segment owns a good market share in the microbial testing market.The large share of this segment is attributed to factors such as the significant adoption of conventional laboratory instruments among researchers and academia (coupled with growing industry-academia collaborations for genomic research), technological advancements in the field of molecular techniques and proteomics (such as the integration of microfluidics with PCR and nanotechnology with qPCR techniques), and the ongoing trend of laboratory automation among clinical laboratories.Reagent estimated to be the growing microbial testing marketThe clinical microbiology reagents market is expected to witness sustained demand during the forecast period, owing to the high prevalence of infectious diseases across major markets (resulting in a growing number of clinical diagnostic procedures), the increasing trend of reagent rental agreements along with instrument sales, and a growing number of life science researches in the field of specific reagents for targeted infectious disease diagnosis and treatment, especially across emerging countries.
According to the new market research report AI in Genomics Market is projected to reach USD 1,671 million by 2025 from USD 202 million in 2020, at a CAGR of 52.7% between 2020 and 2025Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36649899The need to control drug development and discovery costs and time, increasing public and private investments in AI in genomics, and the adoption of AI solutions in precision medicine are driving the growth of this market.However, the lack of a skilled AI workforce and ambiguous regulatory guidelines for medical software are expected to restrain the market growth during the forecast period.Based on functionality, the Artificial Intelligence in Genomics Market is segmented into genome sequencing, gene editing, clinical workflows, and predictive genetic testing & preventive medicine.Genome sequencing was the largest functionality segment in this market in 2019 and is estimated to grow at highest CAGR in coming years.The large share of this segment can be attributed to the use of AI solutions to identify chromosomal disorders, dysmorphic syndromes, teratogenic disorders, and single-gene disorders.Based on offering, the Artificial Intelligence in Genomics Market is segmented into software and services.The software and services segment accounted for largest share of the global AI in genomics market in 2019.Software is needed to generate new insights from large-scale datasets and help understand genomic variations, thus enhancing the search for disease-causing variants and reducing clinical analysis times.
According to the new market research report global Diagnostic Electrocardiograph ECG Market is expected to reach USD 10.3 billion by 2024 from USD 7.5 billion in 2019, at a CAGR of 6.4% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173The Factors such as the rising incidence of lifestyle & cardiovascular diseases and increasing geriatric population are expected to propel the growth of the market.Asia Pacific diagnostic ECG market is expected to grow at the highest CAGR during the forecast periodOn the basis of region, the diagnostic ECG market is segmented into North America, Europe, Asia Pacific, and RoW.The Asia Pacific is expected to grow at the highest CAGR during the forecast period.Factors such as growth in the geriatric population, growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, growing demand for advanced technologies, and less stringent regulations are fueling the demand for diagnostic ECG products and services in this region.The 3-lead ECG segment is expected to grow at the highest CAGR in the diagnostic ECG market during the forecast periodBy lead type, the diagnostic ECG market is divided into 12-lead, 5-lead, 3-lead, 6-lead, single-lead, and other lead types (15- and 18-lead).The 3-lead segment is expected to grow at the highest CAGR during the forecast period.This positive growth is primarily due to the fact that these leads are used conjointly with various other cardiac diagnostic tests and during medical procedures.The hospitals, clinics, and cardiac centers segment accounted for the largest share of the Diagnostic Electrocardiograph (ECG) Market in 2018By end user, the market is classified into hospitals, clinics, and cardiac centers; ambulatory surgical centers; and other end users.In 2018, the hospitals, clinics, and cardiac centers segment accounted for the largest share of the market.
According to research report the Gene Editing Market is projected to reach USD 6.28 billion by 2022 from USD 3.19 billion in 2017, at a CAGR of 14.5% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000The market growth is largely driven by factors such as the rise in government funding, growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics.However, the high cost of genomic equipment will restrain the growth of this market.Based on application, the genome editing/genome engineering market is segmented into cell line engineering, genetic engineering, diagnostic applications, drug discovery & development, and other applications.A number of factors, such as the increased funding from governments and private organizations, growing industry focus on stem cell research, and global awareness are driving market growth in this segment.Pharmaceutical companies accounted for the largest share of the Gene Editing Market, by end user, in 2019.The increasing prevalence of infectious diseases and cancer are driving research activities worldwide.This, in turn, is expected to drive the demand for genome editing in pharmaceutical companies.The CRISPR technology segment accounted for the largest share of the genome editing/genome engineering industry in 2019.The large share of this segment can be attributed to the ease of use associated with CRISPR, which gives it a significant advantage over ZFN and TALEN.
According to the new market research report the global spatial genomics market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170900551The major factors driving the growth of the spatial genomics and transcriptomics market are the increasing adoption of spatial genomics and transcriptomics techniques for drug discovery & development and the increasing R investments and public-private funding.Additionally, the introduction of technologically advanced instruments for spatial genomics analysis is also boosting the market growth.However, the high capital investments associated with spatial genomics and transcriptomics are a major factor restraining market growth.Spatial genomics & transcriptomics market is categorized into major four product categories, techniques, product, application and end user.Among the techniques, spatial transcriptomics techniques segment is expected to grow at the highest CAGR during the forecast period.Growth in this market segmentis attributed to the increasing demand for and high adoption rate of in situ sequencing techniques.Based on product, the global spatial genomics & transcriptomics market is categorized instruments, consumables, and software.The growing applications of spatial genomics and transcriptomics in various fields such as drug discovery & development and biomarker identification and the growing use of consumables are the key factors driving the market growth.On the basis of technique, the spatial genomics market is segmented into spatial transcriptomics techniques and spatial genomics analysis techniques.
More

Top